A Phase 1, Double-Blind, Randomized, Placebo-controlled Leukapheresis Study to Obtain Lymphocytes for the Study of Immune Responses in Healthy Adult Volunteers in the U.S. who receive BCG Vaccination followed by Boosting with AERAS-402.

Trial Profile

A Phase 1, Double-Blind, Randomized, Placebo-controlled Leukapheresis Study to Obtain Lymphocytes for the Study of Immune Responses in Healthy Adult Volunteers in the U.S. who receive BCG Vaccination followed by Boosting with AERAS-402.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Mar 2015

At a glance

  • Drugs Tuberculosis vaccine (Primary) ; BCG vaccine
  • Indications Tuberculosis
  • Focus Pharmacodynamics
  • Sponsors Aeras; Crucell
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Mar 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 21 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top